account_id none on file
legal_name Volitionrx Ltd
ticker VNRX
cik 93314
domain volition.com
linkedin_company_url https://www.linkedin.com/company/volitionrx/
entry_point_account_id none on file
name VolitionRX Limited
exchange NYSE
sector Health Care
hq Henderson, NV, United States
sector index/company/sector/health-care/
calls 2 filings 1 executives 7 family 0
why_nownone on file
calls
Yeah, so we have planned for a lower level of spending this year. So if you remember last year, we had quite a lot of launches in the year, so spending was naturally higher at that point. And now it's, to a certain extent, it's sort of baked into business as usual. So yes, we will continue to attend conferences, particularly those where our partners are present. And if we need to, we will spend money. So it may well be lumpy from one quarter to the next. But overall, we've budgeted to spend less money this year versus last year.
May 16, 2025 / receipt, needs a key / Stephen, other | earnings call 2025-05-16 | transcript f55303a3-f66a-41ca-b3d6-f0c522e4adf8 | chars 23466-24000 | segment 24
One thing I would add as well, Stephen, in terms of what we're doing to try and save money, is we're attending the conferences to do the networking and meet with the KOLs. but we're not necessarily hiring a booth, because that's often what is the costly item at a conference. So that's definitely helped us manage costs, but we are still active. So for example, Dr. Retta and Dr. Terry Kelly are attending ATS this weekend, the American Thoracic Society, but we don't have a booth at that. So then the costs are limited to just registration and then kind of some of the networking costs. So that's a way that we've kind of clawed back.
May 16, 2025 / receipt, needs a key / Stephen, other | earnings call 2025-05-16 | transcript f55303a3-f66a-41ca-b3d6-f0c522e4adf8 | chars 24001-24636 | segment 24
filings
total operating expenses for the quarter were $4.6 million compared to $6.7 million in the same period last year, a 32% reduction year-on-year. This reflected savings from our cost reduction program,
company_statement / Aug 14, 2026 / receipt, needs a key
executives
| Cameron Reynolds | CEO | - | receipt |
| David M. Kratochvil | Chief Financial Officer | - | receipt |
| David Vanston | Chief Financial Officer | - | receipt |
| Jason Terrell MD | Chief Medical Officer | - | receipt |
| Mr. Reynolds | CEO | - | receipt |
| Terig Hughes | Group Chief Financial Officer | - | receipt |
| Terry Cuse | Group Chief Financial Officer | - | receipt |
familynone on file
upcoming
| 2026-11-12 | earnings call | scheduled | ir |
changes
| 2021-02-02 | Chief Financial Officer, appointed | sec_8k |
| 2017-04-12 | Chief Financial Officer, appointed | sec_8k |
| 2017-04-12 | Chief Financial Officer, departed | sec_8k |
| 2016-01-05 | Chief Medical Officer, appointed | sec_8k |
| 2015-08-17 | Chief Financial Officer, appointed | sec_8k |
| 2015-08-17 | Chief Financial Officer, departed | sec_8k |
mcp_package_hint
slug volitionrx-limited
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$